| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |